263 related articles for article (PubMed ID: 2676851)
1. Differences in the induction of macrophage cytotoxicity by the specific T lymphocyte factor, specific macrophage arming factor (SMAF), and the lymphokine, macrophage activating factor (MAF).
De Groot JW; De Weger RA; Vandebriel RJ; Den Otter W
Immunobiology; 1989 Jun; 179(2-3):131-44. PubMed ID: 2676851
[TBL] [Abstract][Full Text] [Related]
2. Lymphocyte-induced macrophage cytotoxicity. III. Induction of specific macrophage cytotoxicity is independent of lipopolysaccharide.
de Weger RA; van Loveren H; de Groot JW; Rangarajan R; den Otter W
Immunobiology; 1986 Apr; 171(3):170-9. PubMed ID: 3486815
[TBL] [Abstract][Full Text] [Related]
3. Studies on macrophage-activating factor (MAF) in antitumor immune responses. I. Tumor-specific Lyt-1+2- T cells are required for producing MAF able to generate cytolytic as well as cytostatic macrophages.
Nakajima H; Fujiwara H; Takai Y; Izumi Y; Sano S; Tsuchida T; Hamaoka T
J Immunol; 1985 Sep; 135(3):2199-205. PubMed ID: 3894520
[TBL] [Abstract][Full Text] [Related]
4. The induction of lymphocytes with the capacity to render macrophages cytotoxic in an allogeneic murine system.
De Weger RA; Pels E; Den Otter W
Immunology; 1982 Nov; 47(3):541-50. PubMed ID: 6215342
[TBL] [Abstract][Full Text] [Related]
5. Production of specific macrophage-arming factor precedes cytotoxic T lymphocyte activity in vivo during tumor rejection.
Dullens HF; De Weger RA; Van der Maas M; Den Besten PJ; Vandebriel RJ; Den Otter W
Cancer Immunol Immunother; 1989; 30(1):28-33. PubMed ID: 2598173
[TBL] [Abstract][Full Text] [Related]
6. Evidence for a gamma-interferon receptor that regulates macrophage tumoricidal activity.
Celada A; Gray PW; Rinderknecht E; Schreiber RD
J Exp Med; 1984 Jul; 160(1):55-74. PubMed ID: 6330272
[TBL] [Abstract][Full Text] [Related]
7. Production of macrophage-activating factor by T lymphocyte clones and correlation with other lymphokine activities.
Kelso A; Glasebrook AL; Kanagawa O; Brunner KT
J Immunol; 1982 Aug; 129(2):550-6. PubMed ID: 7045227
[TBL] [Abstract][Full Text] [Related]
8. Initial immunochemical characterization of specific macrophage-arming factor.
De Weger RA; Vandebriel RJ; Slager H; Mans D; Van Loveren H; Wilbrink B; Dullens HF; Den Otter W
Cancer Immunol Immunother; 1989; 30(1):21-7. PubMed ID: 2598172
[TBL] [Abstract][Full Text] [Related]
9. Human macrophage-activating factors for cytotoxicity. I. Establishment of a human T-cell hybridoma that produces macrophage-activating factors for cytotoxicity.
Higuchi M; Sugimoto M; Kobayashi Y; Osawa T
Microbiol Immunol; 1987; 31(5):469-79. PubMed ID: 3116371
[TBL] [Abstract][Full Text] [Related]
10. Identification of a unique T cell-derived lymphokine that primes macrophages for tumor cytotoxicity.
Kern DE; Grabstein KH; Okuno K; Schreiber RD; Greenberg PD
J Immunol; 1989 Dec; 143(12):4308-16. PubMed ID: 2687379
[TBL] [Abstract][Full Text] [Related]
11. Lymphocyte supernatant-induced human monocyte tumoricidal activity: dependence on the presence of gamma-interferon.
Sadlik JR; Hoyer M; Leyko MA; Horvat R; Parmely M; Whitacre C; Zwilling B; Rinehart JJ
Cancer Res; 1985 May; 45(5):1940-5. PubMed ID: 3921233
[TBL] [Abstract][Full Text] [Related]
12. Activation of murine macrophages. I. Different pattern of activation by poly I:C than by lymphokine or LPS.
Taramelli D; Varesio L
J Immunol; 1981 Jul; 127(1):58-63. PubMed ID: 6787132
[TBL] [Abstract][Full Text] [Related]
13. Two specific T cell factors that initiate immune responses in murine allograft systems. A comparison of biologic functions.
Vandebriel RJ; De Weger RA; Los G; Van Loveren H; Wiegers GJ; Oude Weernink PA; Den Otter W
J Immunol; 1989 Jul; 143(1):66-73. PubMed ID: 2659669
[TBL] [Abstract][Full Text] [Related]
14. Similarities of murine gamma interferon and the lymphokine that renders macrophages cytotoxic.
Kleinschmidt WJ; Schultz RM
J Interferon Res; 1982; 2(2):291-9. PubMed ID: 6811671
[TBL] [Abstract][Full Text] [Related]
15. Impairment of allograft tumor immunity by isotype-like suppression of antigen-specific T cell factors.
Van Loveren H; De Weger RA; Garssen J; Los G; Askenase PW
Transplantation; 1989 Mar; 47(3):504-12. PubMed ID: 2466354
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte-induced macrophage cytotoxicity. Production of specific macrophage arming factor by sensitized Lyt 1+2+ T-lymphocytes.
Pels E; De Weger RA; Den Otter W
Int Arch Allergy Appl Immunol; 1984; 74(2):140-6. PubMed ID: 6609130
[TBL] [Abstract][Full Text] [Related]
17. Thymus-derived lymphocytes produce an immunologically specific macrophage-arming factor.
Evans R; Grant CK; Cox H; Steele K; Alexander P
J Exp Med; 1972 Nov; 136(5):1318-22. PubMed ID: 4117192
[TBL] [Abstract][Full Text] [Related]
18. Interferon-induced enhancement of macrophage-mediated tumor cytolysis and its difference from activation by lymphokines.
Boraschi D; Tagliabue A
Eur J Immunol; 1981 Feb; 11(2):110-4. PubMed ID: 6163639
[TBL] [Abstract][Full Text] [Related]
19. Lymphocyte induced macrophage cytotoxicity: characterization of the macrophage cytotoxicity-inducing lymphocyte.
Pels E; de Weger RA; den Otter W
Immunobiology; 1984 Jan; 166(1):84-95. PubMed ID: 6201434
[TBL] [Abstract][Full Text] [Related]
20. Constitutive production of novel macrophage-activating factor(s) by human T cell hybridomas.
Taniyama T; Taki S; Akiyama Y; Yoshizawa K; Hamuro J; Arai K; Wong GG
Clin Invest Med; 1990 Dec; 13(6):305-12. PubMed ID: 2127737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
